Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | CNR1 | P21554 | 1/20 | 0.62 |
| ▸ | CNR2 | P34972 | 1/20 | 0.62 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.57 |
| ▸ | PRKCA | P17252 | 2/20 | 0.55 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.55 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.55 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.55 |
| ▸ | DGKA | P23743 | 1/20 | 0.54 |
| ▸ | SELP | P16109 | 1/20 | 0.52 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.50 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6250325 | 1.00 | FAAH (0.62) | FAAHALDH1A1MAPTHPGDCNR1 | |
| SCHEMBL9054619 | 1.00 | FAAH (0.62) | FAAHALDH1A1MAPTHPGDCNR1 | |
| SCHEMBL6250351 | 1.00 | FAAH (0.62) | FAAHALDH1A1MAPTHPGDCNR1 | |
| SCHEMBL9055934 | 1.00 | FAAH (0.62) | FAAHALDH1A1MAPTHPGDCNR1 | |
| SCHEMBL12988464 | 0.99 | FAAH (0.64) | FAAHALDH1A1MAPTHPGDCNR1 | |
| SCHEMBL1009144 | 0.99 | FAAH (0.64) | FAAHALDH1A1MAPTHPGDCNR1 | |
| SCHEMBL9055855 | 0.99 | FAAH (0.64) | FAAHALDH1A1MAPTHPGDCNR1 | |
| SCHEMBL1666730 | 0.96 | PRKCA (0.59) | FAAHALDH1A1MAPTHPGDCNR1 | |
| SCHEMBL6252306 | 0.96 | PRKCA (0.59) | FAAHALDH1A1MAPTHPGDCNR1 | |
| SCHEMBL9055938 | 0.96 | PRKCA (0.59) | FAAHALDH1A1MAPTHPGDCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3452482-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF RETT SYNDROME | Neurotrope Bioscience, Inc. (US) | 2019-03-13 | — | — | EP | claimed |
| WO-2018187647-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF NEUROLOGICAL DISEASES, DISORDERS, OR CONDITIONS | NEUROTROPE BIOSCIENCE, INC. (US) | 2018-10-11 | — | — | WO | claimed |
| WO-2017192906-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF RETT SYNDROME | NEUROTROPE BIOSCIENCE, INC. (US) | 2017-11-09 | — | — | WO | claimed |
| EP-3452482-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF RETT SYNDROME | Neurotrope Bioscience, Inc. (US) | 2019-03-13 | — | — | EP | disclosed |
| WO-2018187647-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF NEUROLOGICAL DISEASES, DISORDERS, OR CONDITIONS | NEUROTROPE BIOSCIENCE, INC. (US) | 2018-10-11 | — | — | WO | disclosed |
| WO-2018170414-A1 | NON-VIRAL, NON-CATIONIC NANOPARTICLES AND USES THEREOF | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2018-09-20 | — | — | WO | disclosed |
| WO-2018170398-A1 | ENGINEERED LIPOSOMES AS CANCER-TARGETED THERAPEUTICS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2018-09-20 | — | — | WO | disclosed |
| WO-2017192906-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF RETT SYNDROME | NEUROTROPE BIOSCIENCE, INC. (US) | 2017-11-09 | — | — | WO | disclosed |
| EP-3131543-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF LIPID STORAGE DISORDERS | Neurotrope Bioscience (US) | 2017-02-22 | — | — | EP | disclosed |
| WO-2015160851-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF LIPID STORAGE DISORDERS | NEUROTROPE BIOSCIENCE (US) | 2015-10-22 | — | — | WO | disclosed |
| EP-2654779-A1 | LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF | Ludwig Institute for Cancer Research, Ltd. (US) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012088414-A1 | LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (US) | 2012-06-28 | — | — | WO | disclosed |
| EP-2268272-A2 | COMPOUNDS THAT MODULATE NEGATIVE-SENSE, SINGLE-STRANDED RNA VIRUS REPLICATION AND USES THEREOF | Mount Sinai School of Medicine of New York University (US) | 2011-01-05 | — | — | EP | disclosed |
| WO-2009136979-A2 | COMPOUNDS THAT MODULATE NEGATIVE-SENSE, SINGLE-STRANDED RNA VIRUS REPLICATION AND USES THEREOF | MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY (US) | 2009-11-12 | — | — | WO | disclosed |
| WO-2001068137-A2 | COMPOSITIONS FOR REGULATING MEMORY CONSOLIDATION | BROWN UNIVERSITY RESEARCH FOUNDATION (US) | 2001-09-20 | — | — | WO | disclosed |